
The FDA’s Rapid AI Integration - A Critical Perspective
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
-
Narrated by:
-
By:
About this listen
The FDA just announced it’s going full speed with generative AI—and plans to have it running across all centers in less than two months. That might sound like innovation, but in a regulatory agency where a misplaced comma can delay a drug approval, this is less “visionary leap” and more “hold my beer.” Before we celebrate the end of bureaucratic busywork, let’s talk about what happens when the watchdog hands the keys to the algorithm.
Written by Markus Brinsa.
Narrated by Andrew Fauxley.
Hosted on Acast. See acast.com/privacy for more information.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet